Summary
Updated Aug 30, 2026
Olivier Brandicourt is Director of Vaxcyte, Inc. (PCVX). 5 SEC Form 4 filings on record going back to 2025, most recently on 16 June 2026.
Recent Transactions
5Every recent SEC Form 4 transaction Olivier Brandicourt has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Olivier Brandicourt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John Oyler - $198.67M of ONC open-market activity in the last 12 months
- Chan Henry Lee - $10.78M of ONC open-market activity in the last 12 months
- Xiaobin Wu - $8.75M of ONC open-market activity in the last 12 months
- Grant Pickering - $3.63M of PCVX open-market activity in the last 12 months
- Lai Wang - $2.92M of ONC open-market activity in the last 12 months
- Corazon (Corsee) D. Sanders - $1.86M of ONC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Olivier Brandicourt?
Olivier Brandicourt is a corporate insider, tracked as Director of Vaxcyte, Inc. (PCVX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Olivier Brandicourt submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Olivier Brandicourt's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Olivier Brandicourt and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
